date:Sep 17, 2012
and demonstrate its lipid-based ingredients' health benefits on various infant populations, said Yael Lifshitz, Director of RD at Enzymotec Infant Nutrition. We developed this innovative ingredient and educated the premium infant formula market over the last several years. Enzymotec invested 10% of its revenue in research and development - a percentage considered among the highest in the industry.